331920 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Celemics, Inc. engages in the provision of biotechnology services. It operates through Next Generation Sequencing (NGS) Services and Consumable Products businesses. The NGS Services business offers whole genome, whole exome, targeted, and other sequencing. The company was founded in October 2010 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
331920 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company